Key result
Dofetilide and quinidine, as well as ranolazine, caused significant T wave morphology changes, whereas strong calcium and hERG block with verapamil did not.
Why the study?
Does administration of multichannel blocking drugs (quinidine, ranolazine, verapamil) prevent T wave morphology changes compared to pure hERG block (dofetilide) in healthy subjects?
RCT (n=22)
Placebo-controlled
Cross-over
Does administration of multichannel blocking drugs (quinidine, ranolazine, verapamil) prevent T wave morphology changes compared to pure hERG block (dofetilide) in healthy subjects?
Multichannel block with quinidine and ranolazine does not prevent T wave morphology changes compared to pure hERG block, indicating that T wave morphology changes are directly related to the amount of hERG block.
Answers are grounded in this paper and cite their sources.
Multichannel block with quinidine or ranolazine fails to prevent T wave changes; confirms these track hERG block magnitude independent of calcium effects.
BACKGROUND: Congenital long QT syndrome type 2 (abnormal hERG potassium channel) patients can develop flat, asymmetric, and notched T waves. Similar observations have been made with a limited number of hERG-blocking drugs. However, it is not known how additional calcium or late sodium block, that can decrease torsade risk, affects T wave morphology. METHODS AND RESULTS: Twenty-two healthy subjects received a single dose of a pure hERG blocker (dofetilide) and 3 drugs that also block calcium or sodium (quinidine, ranolazine, and verapamil) as part of a 5-period, placebo-controlled cross-over trial. At pre-dose and 15 time-points post-dose, ECGs and plasma drug concentration were assessed. Patch clamp experiments were performed to assess block of hERG, calcium (L-type) and late sodium currents for each drug. Pure hERG block (dofetilide) and strong hERG block with lesser calcium and late sodium block (quinidine) caused substantial T wave morphology changes (P<0.001). Strong late sodium current and hERG block (ranolazine) still caused T wave morphology changes (P<0.01). Strong calcium and hERG block (verapamil) did not cause T wave morphology changes. At equivalent QTc prolongation, multichannel blockers (quinidine and ranolazine) caused equal or greater T wave morphology changes compared with pure hERG block (dofetilide). CONCLUSIONS: T wave morphology changes are directly related to amount of hERG block; however, with quinidine and ranolazine, multichannel block did not prevent T wave morphology changes. A combined approach of assessing multiple ion channels, along with ECG intervals and T wave morphology may provide the greatest insight into drug-ion channel interactions and torsade de pointes risk. CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov/ Unique identifier: NCT01873950.
No takes yet. Share an insight, caveat, or question.
Vicente et al. (2015) conducted an RCT in Healthy subjects (n=22). Dofetilide, quinidine, ranolazine, and verapamil vs. Placebo was evaluated on T wave morphology changes (p=<0.001). Dofetilide and quinidine, as well as ranolazine, caused significant T wave morphology changes, whereas strong calcium and hERG block with verapamil did not.
Synapse has enriched 10 related papers. Consider them for comparative context: